Pathology managed service for Kettering General Hospital comes from Roche
- Kettering General Hospital NHS Foundation Trust
- East Midlands
- Call-off from a framework agreement, 1 bid
- 4 June 2026 to 3 June 2036
Kettering General Hospital NHS Foundation Trust has a ten-year pathology managed service from Roche Diagnostics. The trust belongs to the Midlands East 2 Pathology Network, nine NHS trusts that procured the service together.
Phase 1 of the service covers blood sciences. In phase 2, Roche takes on other pathology disciplines through sub-contractors.
The network picked Roche through a mini-competition on Lot 1 of NHS Supply Chain's Laboratory Diagnostics, Point of Care Testing and Pathology Managed Services framework. It drew one bid. Kettering General then signed its own contract with Roche. Worth £13m, it was awarded in June 2026 and runs to June 2036.
Contract ends June 2036
- What
- Pathology managed services and blood sciences analysers
- Supplier
- Roche Diagnostics
- Value
- £13m
- How it was bought
- Call-off from a framework agreement
- 1 bid
- Dates and next
- Jun 2026 to Jun 2036